Guide · Recherche sur les peptides
Why negative trials matter in peptide research
Learn how a well-designed negative study updates an evidence record, why absence of significance is not always proof of no effect, and why unfavorable findings are easy to miss.
Réponse directe
Réponse directe
A negative trial can rule out meaningful effects within its confidence interval, contradict a promising preclinical story, reveal feasibility or safety problems, and prevent repeated dead ends. Its meaning depends on design quality and precision: an inconclusive small study is different from a precise result that excludes an important effect.
Ce qui compte
- Negative evidence is evidence, not an empty result.
- Read confidence intervals to distinguish exclusion from uncertainty.
- Compare prespecified primary outcomes with emphasized secondary findings.
- Search registries because unfavorable studies may be less visible in journals.
Negative trials test the translation step
A peptide can show receptor activity, animal effects, or an early human signal and still fail to improve the relevant outcome in a controlled study. That result updates the mechanism-to-outcome story rather than erasing the earlier observations.
Negative translation is especially informative when the human study directly tests the promoted claim with a suitable comparator.
Negative and inconclusive are not synonyms
A wide confidence interval may include meaningful benefit, no effect, and meaningful harm. That study leaves substantial uncertainty even if a conventional threshold is not crossed.
A precise interval that excludes an important benefit supports a stronger negative conclusion for that population, formulation, outcome, and time frame.
Counter selective visibility
Positive findings are often easier to publish, promote, and repeat. Search trial registries for completed studies, posted results, and missing publications, and inspect whether secondary outcomes displaced the prespecified primary outcome in public summaries.
Peptidia surfaces material negative studies beside positive evidence so readers can see the direction and limits of the whole record.
Consulter le dossier
Sources
- 01U.S. National Library of Medicine
- 02Cochrane
- 03Cochrane
Aller plus loin
Gardez la bibliothèque de données probantes dans votre poche.
Peptidia pour iPhone ajoute la bibliothèque révisée complète, des fiches d’études consultables, des questions étayées et un journal de bien-être privé — sans données posologiques numériques ni protocoles.